WWM
LTRN icon

Wolff Wiese Magana’s Lantern Pharma LTRN Stock Holding History

Wolff Wiese Magana’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-600
Closed -$2.2K – 993
2024
Q3 		$2.2K Hold
600
– – ﹤0.01% 724
2024
Q2 		$2.8K Hold
600
– – ﹤0.01% 502
2024
Q1 		$5.28K Hold
600
– – ﹤0.01% 383
2023
Q4 		$2.57K Sell
600
-1,600
-73% -$5.64K ﹤0.01% 449
2023
Q3 		$7.5K Sell
2,200
-22,945
-91% -$104K 0.01% 381
2023
Q2 		$142K Sell
25,145
-1,333
-5% -$6.89K 0.11% 116
2023
Q1 		$128K Sell
26,478
-620
-2% -$3.26K 0.1% 119
2022
Q4 		$164K Sell
27,098
-3,364
-11% -$16.8K 0.14% 105
2022
Q3 		$146K Sell
30,462
-1,113
-4% -$5.98K 0.12% 134
2022
Q2 		$180K Sell
31,575
-4,580
-13% -$27.3K 0.13% 124
2022
Q1 		$259K Buy
36,155
+2,020
+6% +$13.5K 0.17% 104
2021
Q4 		$272K Sell
34,135
-1,181
-3% -$10.8K 0.18% 111
2021
Q3 		$395K Buy
35,316
+6,997
+25% +$90.5K 0.28% 87
2021
Q2 		$413K Buy
28,319
+1,244
+5% +$19.2K 0.29% 82
2021
Q1 		$491K Buy
+27,075
New +$475K 0.38% 61

Other funds holding LTRN

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return

Wolff Wiese Magana's LTRN Position: Q4 2024 in Review

Wolff Wiese Magana sold out of Lantern Pharma (LTRN) in Q4 2024, closing a stake of 600 shares — an estimated $2.2K sold.

Wolff Wiese Magana first reported a position in LTRN in Q1 2021 and held it in 15 quarters. The position peaked at $491K in Q1 2021. 32 funds tracked by Wall St. Rank hold LTRN as of Q4 2024.

  • Wolff Wiese Magana reported no remaining Lantern Pharma position as of Q4 2024 after selling out during the quarter.
  • Wolff Wiese Magana sold 600 Lantern Pharma shares in Q4 2024, an estimated $2.2K.
  • Wolff Wiese Magana first reported a position in Lantern Pharma in Q1 2021 and held it in 15 quarters.
  • Wolff Wiese Magana's Lantern Pharma position peaked at $491K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Lantern Pharma as of Q4 2024.

Based on Wolff Wiese Magana's 13F filing for Q4 2024, filed 14 Jan 2025.